Full Agenda (subject to change)

Speaker: Tadeusz Robak, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Chair: Bartosz Pula, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Co-Chair: Elisa ten Hacken, PhD – Weill Cornell Medicine

Co-Chair: Emanuela M. Ghia, PhD – Center for Novel Therapeutics; University of California, San Diego

Co-Chair: Marek Mraz, MD, PhD – CEITEC Masaryk University and University Hospital Brno

Co-Chair: Alan G. Ramsay, PhD – Lymphoma Immunology Group, Kings College London

Co-Chair: Philip Thompson, MB, BS (Hons) – Peter MacCallum Cancer Centre & Royal Melbourne Hospital; The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne

Co-Chair: Erin M. Parry, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Moritz Fürstenau, MD – Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne and Duesseldorf, German CLL Study Group, Faculty of Medicine and University Hospital Cologne, University of Cologne

Co-Chair: Elżbieta Iskierka-Jażdżewska, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital in Lodz, Poland

Co-Chair: Bartosz Pula, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Co-Chair: Marek Mraz, MD, PhD – CEITEC Masaryk University and University Hospital Brno

Chair: Tadeusz Robak, MD, PhD – Department of Hematology, Medical University of Lodz; Department of General Hematology and Internal Medicine, Copernicus Memorial Hospital

Speaker: Iwona Hus, MD, PhD – National Medical Institute of the Ministry of the Interior and Administration

Speaker: Thomas J. Kipps, MD, PhD – UC San Diego, Moores Cancer Center

Co-Chair: Catherine Wu, MD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: Stephan Stilgenbauer, MD – Division of CLL, Internal Medicine III, Ulm University

Co-Chair: Thorsten Zenz, MD – University of Zurich

Co-Chair: Sarka Pospisilova, PhD – Masaryk University and University Hospital Brno

Co-Chair: Nicholas Chiorazzi, MD – The Feinstein Institutes for Medical Research, Northwell Health System

Co-Chair: Martina Seiffert, PhD – German Cancer Research Center

Co-Chair: Paolo Ghia, MD, PhD – Università Vita Salute and IRCCS Ospedale San Raffaele

Co-Chair: Shih-Shih Chen, PhD – The Feinstein Institutes for Medical Research

Co-Chair: Barbara Eichhorst, MD – Department I of Internal Medicine, University Hospital of Cologne

Co-Chair: William G. Wierda, MD, PhD – The University of Texas MD Anderson Cancer Center

Co-Chair: Jennifer R. Brown, MD, PhD – Dana-Farber Cancer Institute, Harvard Medical School

Co-Chair: John Seymour, MBBS, PhD, FRACP – Peter MacCallum Cancer Centre & Royal Melbourne Hospital

Co-Chair: Gianluca Gaidano, MD, PhD – University of Eastern Piedmont, Maggiore Charity Hospital

Co-Chair: Silvia Deaglio, MD, PhD – University of Turin

Co-Chair: Carsten U. Niemann, MD, PhD – Rigshospitalet, Copenhagen University Hospital

Co-Chair: Brian Koffman, MD – CLL Society, Inc., Chula Vista

Co-Chair: Jennifer A. Woyach, MD – Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center

Co-Chair: Francesc Bosch, MD, PhD – Universtitat Autonoma Barcelona, Hospital Universitari Vall d'Hebron

Co-Chair: Arnon P. Kater, MD, PhD – Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, and HOVON

Co-Chair: Maria Teresa Sabrina Bertilaccio, PhD – The University of Texas MD Anderson Cancer Center

Keynote Speaker: Krzysztof Jamroziak, MD, PhD – Medical University of Warsaw

Co-Chair: Anna Schuh, MD, PhD – Churchill Hospital, Oxford University

Co-Chair: Raúl Gabus, MD – Hospital Maciel, ASSE

Co-Chair: Thomas J. Kipps, MD, PhD – UC San Diego, Moores Cancer Center

Co-Chair: Michael Hallek, MD, PhD – German CLL Study Group, University Hospital of Cologne